KYROGENE PRIVATE LIMITED
New Delhi, Delhi
In their own words
Kyrogene provides Epigene therapy to help prevent, manage or reverse autoimmune disorders. Kyrogene monitors epigenetics through gene studies including methylation, histone modification & noncoding RNAs in the context of the digital twin of the individual. Kyrogene can determine the exact gene that needs to be modulated and identify the precise changes in external factors which could trigger this modulation. Using this approach, certain diseases are expected to be cured, prevented, eliminated or made milder in some cases. Kyrogene is not a healthcare company. Kyrogene uses data science on digital twins to help a doctor to find the root cause external factor that is triggering or worsening the auto immune disease.
Written by the company on its public Startup India profile. Not verified by us.
What the record says
- DPIIT recognition number
- DIPP92243
- CIN
- U73200DL2021PTC389497
- Incorporated (MCA)
- 2021
- Registered on Startup India
- 2021
- Self-declared stage
- Prototype
- MCA status
- Active
- Company class
- Private
- Registrar
- RoC-Delhi II
- Authorised capital
- ₹12,00,000
- Paid-up capital
- ₹11,30,000
Where this is
Locality
New Delhi
Delhi
We know the area, New Delhi, but not the address. The pin below covers roughly a kilometre.
Geocode confidence: medium
What we do not know
- no website on file
- no funding signal of any kind
We have no liveness signal for any company on this site: no filings feed, no revenue, no check that the website still resolves. A record existing here means a record exists, not that a business is trading.
Is this your company?
Everything here comes from public government records. If something is wrong, the authoritative place to correct it is the Startup India portal itself, and we will pick the correction up on the next monthly snapshot. To flag an error on our side, write to trust@indianstartupmap.com.